United StatesWhat do you think?
We invite your feedback
as
we continue to improve and expand the value of our Web site.
About Us
News and Press Releases
2011 News
2010 News
2009 News
2008 News
2007 News
2006 News
2005 News
- December 19, 2011
New BD Veritor™ System for Rapid Detection of Flu A+B Receives 510(k) Clearance and CLIA Waiver - November 24, 2011
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug - September 13, 2011
BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative® - August 18, 2011
BD Diagnostics and Biodiversity Collaborate to Develop Portfolio of Assays on the BD MAX™ System - August 3, 2011
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System - July 1, 2011
BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline - May 19, 2011
BD Launches BD MAX™ System in U.S. to Empower Laboratories and Clinicians to Respond to Emerging Diseases - May 9, 2011
BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System - May 8, 2011
Bruker Announces Integrated Microbiology Workflow For MALDI Biotyper Microbial Identification and BD Phoenix™ Antibiotic Susceptibility Testing - March 28, 2011
BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens - March 21, 2011
World TB Day Donation Campaign Increases Access to Improved TB Tests in Resource-Limited Settings - February 16, 2011
BD Expands Industrial Microbiology Rapid Methods Portfolio - February 9, 2011
BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers - January 3, 2011
New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients
2010 News
- December 20, 2010
BD Diagnostics Facility in Mebane, North Carolina Achieves LEED Silver Certification for Green Building Design - November 16, 2010
BD Taps Leading Voice in Infection Prevention Community to Advance Efforts to Reduce Healthcare-Associated Infections - October 25, 2010
BD Diagnostics and Lonza Collaborate to Commercialize the Lonza microCompass™ Molecular Assays on the BD MAX™ System - September 29, 2010
BD Diagnostics and Bruker Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing - August 3, 2010
BD Receives CLIA "Moderate Complexity" Status for the BD MAX™ GBS Assay - June 17, 2010
Launch of BD BACTEC™ MGIT™ 320 System Expands TB Detection Worldwide - June 2, 2010
BD Announces First FDA-Cleared Assay on the BD MAX™ System to Detect Group B Streptococcus - May 20, 2010
BD Celebrates Opening of Manufacturing Facility in Mebane, North Carolina - April 6, 2010
BD Expands Diagnostics Portfolio with Advanced Automated Microbiology Specimen Processor - March 18, 2010
BD Diagnostics Launches the BD Protect™ Infection Surveillance and Prevention Software Portfolio - February 3, 2010
BD Launches "Be a Flu Fighter" Campaign to Promote Influenza Awareness and Prevention in Schools, Hospitals and Laboratories
2009 News
- December 7, 2009
BD Expands Diagnostic Testing Offerings in Women's Health - November 20, 2009
BD Completes Acquisition of HandyLab, Inc. - November 5, 2009
BD Diagnostics Launches Turnkey Continuing Education Program for Clinical Laboratories - October 23, 2009
BD Announces Agreement to Acquire HandyLab, Inc. - August 6, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio - March 23, 2009
BD Announces FDA 510(k) Clearance of BD ProbeTec™ Qx Amplified Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae - February 10, 2009
BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae - January 14, 2009
New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Operating System now Available Worldwide - January 12, 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
2008 News
- July 7, 2008
BD GeneOhm™ Cdiff Assay Submitted for FDA Clearance - June 2, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections - April 8, 2008
BD Opens New Manufacturing Facility in Suzhou, China to Produce Rapid Diagnostic Products - March 27, 2008
BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana - March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates - January 2, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
2007 News
- December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens - September 11, 2007
BD Announces FDA 510(k) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery - May 22, 2007
BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing - April 26, 2007
Ability of the BD ProbeTec™ ET System to Detect Variant Chlamydia trachomatis is Confirmed - March 22, 2007
BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics Worldwide - March 9, 2007
BD Honored as One of "America's Most Admired Companies" in FORTUNE Magazine's Annual Rankings - February 8, 2007
BD Commits $34 Million for Major Expansion in Québec
2006 News
- December 20, 2006
BD Completes Acquisition of TriPath Imaging, Expands Presence in Cancer Diagnostics Market - July 18, 2006
BD Invests US$16 Million to Establish a Plant in China To Produce Rapid Diagnostic Products for Flu and Virus Infection - June 15, 2006
BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper™ Robotic Instrumentation and Molecular Testing of Sexually Transmitted Infections - February 23, 2006
BD Diagnostics Announces Multi-year Agreement with Quest Diagnostics for BD Viper™ System - January 9, 2006
BD Diagnostics Announces FDA 510(k) clearance of the BD Viper™ System
2005 News
- October 19, 2005
BD Diagnostics Announces FDA 510(k) Clearance for BD ProbeTec™ Urine Preservative Transport (UPT) - September 22, 2005
BD Diagnostics Announces FDA 510(k) Clearance of BD Directigen™ EZ Flu A+B Test - August 31, 2005
BD Directigen™ EZ Flu A+B Test - A better option for Flu testing is now available - August 10, 2005
BBL™ CHROMagar™ Listeria Receives AOAC™ Certification for the Direct Identification of L. monocytogenes and L. ivanovii - July 18, 2005
BD Universal Viral Transport - Room Temperature Viability - June 2, 2005
Launching Our Newly Reconfigured Web Site - April 10, 2005
BBL™ CHROMagar™ Salmonella Medium Receives AOAC-RI Approval - March 30, 2005
BD EpiCenter™ Version 5: Provides New Capabilities - January 11, 2005
BD GasPak™ EZ Gas Generating Systems are rapid, waterless and catalyst-free - January 10, 2005
BD Announces FDA 510(k) clearance of simplified test for detection of methicillin-resistant Staphylococcus aureus (MRSA) - January 1, 2005
BBL™ CHROMagar™ Orientation – Save time and reduce costs with a single plate culture system that identifies 80% of urinary pathogens without confirmatory testing.
